Virus News and Research

Latest Virus News and Research

Southern Chicago healthcare provider takes extra precautions to prevent H1N1 virus

There have been some new changes to the visitor guidelines at Riverside Medical Center. With the recent upswing in the number of people infected with the H1N1 virus, the southern Chicago suburbs healthcare provider has decided that there should be extra precautions put in place to protect patients, visitors and staff during this influenza outbreak.

31 Dec 2009

Scientists discover a new family of giant virus

After Mimivirus, Mamavirus and the virophage, the group of giant viruses now has a new member called Marseillevirus. Discovered in an amoeba by the team led by Didier Raoult at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes research group (CNRS/Université Aix-Marseille 2), a description of this new virus was published this week on the website of the Proceedings of the National Academy of Sciences (PNAS).

31 Dec 2009

Rite Aid offers H1N1 flu shots through certified immunizing pharmacists

Rite Aid now is offering the H1N1 (swine) flu shots by its certified immunizing pharmacists at 1,257 Rite Aid stores in 30 states and the District of Columbia. Customers can go to www.riteaid.com/H1N1 to find the most convenient Rite Aid store offering the H1N1 flu shots.

31 Dec 2009

Study says short-term school closures during flu pandemic may increase infection rates

Closing schools for less than two weeks during a flu pandemic may increase infection rates and prolong an epidemic, say University of Pittsburgh researchers in a study published ahead-of-print and online in the Journal of Public Health Management and Practice.

31 Dec 2009

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

The presence of the Streptococcus pneumoniae in samples that can be easily obtained in clinics and emergency rooms may predict risk of severe disease in H1N1 pandemic influenza.

31 Dec 2009

U.S. Congress designates January as ‘Cervical Health Awareness Month’

Nearly 4,000 women in America will die this year from cervical cancer. These cancers are, largely, preventable, and raising public awareness can save lives. It's why the U.S. Congress has designated January as Cervical Health Awareness Month.

31 Dec 2009

Young people more likely to catch swine flu from an infected person in their household

Young people aged under 18 years are more likely than adults to catch swine flu from an infected person in their household, according to a new study published today in the New England Journal of Medicine.

30 Dec 2009

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel “lipidoid” formulations for the systemic delivery of RNAi therapeutics.

30 Dec 2009

Researchers develop automated system to differentiate strains of influenza

Researchers from the Medical College of Wisconsin, the Children's Research Institute, and the Children's Hospital of Wisconsin have developed a rapid, automated system to differentiate strains of influenza.

30 Dec 2009

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis’ therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.

29 Dec 2009

Canadian Health deploys IceWEB's GIS server technology to combat the growth of H1N1 Flu virus

IceWEB, Inc., www.IceWEB.com, a leading provider of purpose built appliances and building blocks for cloud storage networks, announced today that Canadian Health has deployed IceWEB high performance GIS (Geographic Information System) server technology to augment their efforts to combat the growth of the H1N1 Flu virus.

28 Dec 2009

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies. Now, a new report in the December 24th issue of Cell, a Cell Press publication, suggests that their strategy might do one better: The Wolbachia bacteria also makes the mosquitoes more resistant to infection by viruses that are a growing threat to humans, including those responsible for dengue fever and Chikungunya.

28 Dec 2009

New series of 30-second PSAs on getting vaccinated against H1N1 flu

The U.S. Department of Health and Human Services (HHS), in conjunction with the Ad Council and the Jim Henson Company, has released a new series of 30-second public service announcements (PSAs) about the importance of getting the 2009 H1N1 vaccine. Targeted to parents and children, the PSA campaign features 15 governors, a state first lady, a state chief medical officer and the main character from the PBS’ series “Sid the Science Kid” and reminds the public that getting vaccinated is the best way to stay healthy during this flu season.

24 Dec 2009

EGCg in green tea inhibits flu infection

Joint research conducted by the Central Research Institute of ITO EN, Ltd. and Professor Takashi Suzuki of the School of Pharmaceutical Sciences, University of Shizuoka, showed that epigallocatechin gallate (EGCg), a kind of catechin contained in green tea, had an inhibitory effect against three types of influenza viruses, including the swine-origin H1N1 virus that caused pandemic flu in 2009, and that its effect did not depend on the type of virus. These findings once again suggest that green tea is effective in preventing flu.

24 Dec 2009

More H1N1 vaccines available in U.S., many Americans don't want it

While an increasing number of H1N1 (swine flu) vaccines are available in the U.S., "more than half of American adults say they still don't want it, and one-third of parents say they don't want their children to get it either, according to two surveys," the Washington Post reports. "As of this week, 111 million doses of vaccine against the pandemic strain of H1N1 flu have been released to states and cities.

24 Dec 2009

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

24 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Food safety leader organizes holiday recipe contest to highlight food borne illness

It's not too late! Enter the National Pasteurized Eggs, (www.SafeEggs.com), makers of Davidson's Safest Choice Pasteurized Shell Eggs, best holiday recipe contest. Designed by National Pasteurized Eggs, food safety leader, to celebrate the season and remind at-home chefs and bakers about food borne illness, the Davidson's Safest Choice "Safest Recipes" contest runs through Dec. 31, 2009.

23 Dec 2009

National MS Society calls for grant applications to examine the impact of CCSVI hypothesis

2009 saw exciting research progress, unprecedented opportunities on the horizon, and more scientists than ever working on resolving important questions. Despite the year's economic and financial challenges, the National Multiple Sclerosis Society continues to propel research forward to end MS. In 2009 the Society provided over $33.5 million to support 345 new and ongoing projects in its research portfolio, plus $1.5 million for Fast Forward, the Society's drug development subsidiary which continues to attract new funding streams.

23 Dec 2009

Hand sanitizers become popular promotional products

The Advertising Specialty Institute® announced that hand sanitizers now rival pens as the most popular logoed items that companies are giving away to clients and employees.

23 Dec 2009

Virus News and Research

Latest Virus News and Research

Southern Chicago healthcare provider takes extra precautions to prevent H1N1 virus

Scientists discover a new family of giant virus

Rite Aid offers H1N1 flu shots through certified immunizing pharmacists

Study says short-term school closures during flu pandemic may increase infection rates

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

U.S. Congress designates January as ‘Cervical Health Awareness Month’

Young people more likely to catch swine flu from an infected person in their household

Advances in development of “lipidoid” formulations for systemic delivery of RNAi therapeutics

Researchers develop automated system to differentiate strains of influenza

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Canadian Health deploys IceWEB's GIS server technology to combat the growth of H1N1 Flu virus

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

New series of 30-second PSAs on getting vaccinated against H1N1 flu

EGCg in green tea inhibits flu infection

More H1N1 vaccines available in U.S., many Americans don't want it

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

Majority of Australians think H1N1 vaccination is not necessary

Food safety leader organizes holiday recipe contest to highlight food borne illness

National MS Society calls for grant applications to examine the impact of CCSVI hypothesis

Hand sanitizers become popular promotional products

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in